Anti-angiogenesis drugs have been making waves as treatments for some cancers. Researchers have been developing new biomarkers to map the progress of these therapies, including those that target integrin expression. However, a new study published online yesterday in the Journal of Nuclear Medicine indicates that integrin expression imaging may not provide a mirror image of the impact of peptide therapy as it occurs. {read more here}

Contrast-enhanced (CE) PET/CT provides a more precise assessment of distant metastasis, scalene node metastasis, and peritoneal dissemination in patients with pancreatic cancer, according to a study published in the European Journal of Radiology.  {read more here}

Myocardial perfusion imaging (MPI) with PET and F-18 flurpiridaz may reduce radiation dose while still providing comparable image quality to SPECT, the current standard, according to a study presented at the recent American Society of Nuclear Cardiology (ASNC) Annual Scientific Session held in Boston from Sept 18-21. {read more here}

In honor of World Alzheimer’s Month, here is a recap of the most recent studies and findings about Alzheimer’s Disease. {read more here}